Consider the context: Ras/ERK and PI3K/AKT/mTOR signaling outcomes are pituitary cell type-specific
- PMID: 28445712
- DOI: 10.1016/j.mce.2017.04.019
Consider the context: Ras/ERK and PI3K/AKT/mTOR signaling outcomes are pituitary cell type-specific
Abstract
Conserved signaling pathways are critical regulators of pituitary homeostasis and, when dysregulated, contribute to adenoma formation. Pituitary adenomas are typically benign and rarely progress to malignant cancer. Pituitary and other neuroendocrine cell types often display non-proliferative responses to ERK and PI3K, in contrast to non-endocrine cell types which typically proliferate in response to ERK and PI3K activation. These differences likely contribute to the infrequent progression to malignancy in many endocrine tumors. In this review, we highlight the Ras/ERK and PI3K/AKT/mTOR signaling pathways in each pituitary cell type, as well as in other endocrine tissues. Furthermore, we provide evidence that a balance of ERK and PI3K signaling is required to maintain pituitary homeostasis. It is unlikely that one sole oncogene will be identified as being responsible for sporadic pituitary adenoma formation. This review emphasizes the necessity to consider endocrine cell-specific contexts and the interplay of signaling pathways to define the mechanisms underlying pituitary tumorigenesis.
Keywords: Adenoma; ERK; Lactotrope; MAPK; PI3K; Pituitary.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
cAMP signalling in the normal and tumorigenic pituitary gland.Mol Cell Endocrinol. 2014 Jul 5;392(1-2):37-50. doi: 10.1016/j.mce.2014.05.004. Epub 2014 May 17. Mol Cell Endocrinol. 2014. PMID: 24845420 Review.
-
Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis.Expert Opin Ther Targets. 2009 Sep;13(9):1121-34. doi: 10.1517/14728220903170675. Expert Opin Ther Targets. 2009. PMID: 19637976 Review.
-
The Balance of PI3K and ERK Signaling Is Dysregulated in Prolactinoma and Modulated by Dopamine.Endocrinology. 2018 Jun 1;159(6):2421-2434. doi: 10.1210/en.2017-03135. Endocrinology. 2018. PMID: 29726995 Free PMC article.
-
PI3K/Akt/mTOR and Raf/MEK/ERK signaling pathways perturbations in non-functioning pituitary adenomas.Endocrine. 2012 Oct;42(2):285-91. doi: 10.1007/s12020-012-9682-3. Epub 2012 May 3. Endocrine. 2012. PMID: 22552912 Review.
-
Pituitary Tumorigenesis-Implications for Management.Medicina (Kaunas). 2023 Apr 21;59(4):812. doi: 10.3390/medicina59040812. Medicina (Kaunas). 2023. PMID: 37109772 Free PMC article. Review.
Cited by
-
The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas-New Potential Therapeutic Approach-A Systematic Review.Int J Mol Sci. 2023 Jun 30;24(13):10952. doi: 10.3390/ijms241310952. Int J Mol Sci. 2023. PMID: 37446128 Free PMC article. Review.
-
The Pituitary Transcriptional Response Related to Feed Conversion in Pigs.Genes (Basel). 2019 Sep 14;10(9):712. doi: 10.3390/genes10090712. Genes (Basel). 2019. PMID: 31540087 Free PMC article.
-
Sex-based differences in growth-related IGF1 signaling in response to PAPP-A2 deficiency: comparative effects of rhGH, rhIGF1 and rhPAPP-A2 treatments.Biol Sex Differ. 2024 Apr 8;15(1):34. doi: 10.1186/s13293-024-00603-5. Biol Sex Differ. 2024. PMID: 38589872 Free PMC article.
-
Expression and methylation status of LAMA2 are associated with the invasiveness of nonfunctioning PitNET.Ther Adv Endocrinol Metab. 2019 Jan 29;10:2042018818821296. doi: 10.1177/2042018818821296. eCollection 2019. Ther Adv Endocrinol Metab. 2019. PMID: 30728939 Free PMC article.
-
IMPACT OF REAL-LIFE ENVIRONMENTAL EXPOSURES ON REPRODUCTION: Impact of developmental exposures to endocrine-disrupting chemicals on pituitary gland reproductive function.Reproduction. 2024 Oct 18;168(6):e240072. doi: 10.1530/REP-24-0072. Print 2024 Dec 1. Reproduction. 2024. PMID: 39159262 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
